APA (7th ed.) Citation

Michels, S., Massutí, B., Vasyliv, I., Stratmann, J., Frank, J., Adams, A., . . . Wolf, J. (2024). Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer: Final results of the EUCROSS trial. ESMO open, 9(2), . https://doi.org/10.1016/j.esmoop.2024.102237

Chicago Style (17th ed.) Citation

Michels, Sebastian, et al. "Overall Survival and Central Nervous System Activity of Crizotinib in ROS1-rearranged Lung Cancer: Final Results of the EUCROSS Trial." ESMO Open 9, no. 2 (2024). https://doi.org/10.1016/j.esmoop.2024.102237.

MLA (9th ed.) Citation

Michels, Sebastian, et al. "Overall Survival and Central Nervous System Activity of Crizotinib in ROS1-rearranged Lung Cancer: Final Results of the EUCROSS Trial." ESMO Open, vol. 9, no. 2, 2024, https://doi.org/10.1016/j.esmoop.2024.102237.